CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation
暂无分享,去创建一个
[1] Imre Lengyel,et al. Zinc Binding to the Tyr402 and His402 Allotypes of Complement Factor H: Possible Implications for Age-Related Macular Degeneration , 2011, Journal of molecular biology.
[2] S. Normand,et al. Hospital volume and 30-day mortality for three common medical conditions. , 2010, The New England journal of medicine.
[3] David Hinkley,et al. Bootstrap Methods: Another Look at the Jackknife , 2008 .
[4] B. Rosner,et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. , 2007, JAMA.
[5] J. Vander,et al. The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration: AREDS Report No 17 , 2006 .
[6] S. Perkins,et al. Unravelling protein-protein interactions between complement factor H and C-reactive protein using a multidisciplinary strategy. , 2010, Biochemical Society transactions.
[7] Ami Miller,et al. Complement factor H-ligand interactions: self-association, multivalency and dissociation constants. , 2012, Immunobiology.
[8] Gabriëlle H S Buitendijk,et al. Association of Smoking and CFH and ARMS2 Risk Variants With Younger Age at Onset of Neovascular Age-Related Macular Degeneration. , 2015, JAMA ophthalmology.
[9] S. Hawken,et al. Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study. , 2015, Ophthalmology (Rochester, Minn.).
[10] M. DeAngelis,et al. Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors , 2016, Eye and Vision.
[11] A. Ramé. [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.
[12] J. Wittes,et al. Should we test for genotype in deciding on age-related eye disease study supplementation? , 2015, Ophthalmology.
[13] J. Haines,et al. Peripheral reticular pigmentary change is associated with complement factor H polymorphism (Y402H) in age-related macular degeneration. , 2008, Ophthalmology.
[14] Ivana K. Kim,et al. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. , 2013, Ophthalmology.
[15] Thomas A Gerds,et al. Estimating a time‐dependent concordance index for survival prediction models with covariate dependent censoring , 2013, Statistics in medicine.
[16] B. Rosner,et al. Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis , 2016, British Journal of Ophthalmology.
[17] Martin Krzywinski,et al. Points of Significance: Sampling distributions and the bootstrap , 2015, Nature Methods.
[18] J. Schmier,et al. Patterns and costs associated with progression of age-related macular degeneration. , 2012, American journal of ophthalmology.
[19] Johanna M Seddon,et al. Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. , 2011, Ophthalmology.
[20] M. Daly,et al. Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. , 2012, Investigative ophthalmology & visual science.
[21] M. Kenward,et al. An Introduction to the Bootstrap , 2007 .
[22] K. Baggerly,et al. Genetic Polymorphisms of CFH and ARMS2 Do Not Predict Response to Antioxidants and Zinc in Patients with Age-Related Macular Degeneration: Independent Statistical Evaluations of Data from the Age-Related Eye Disease Study. , 2017, Ophthalmology.
[23] G. Abecasis,et al. No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38. , 2014, Ophthalmology.
[24] T. Peto,et al. High concentration of zinc in sub-retinal pigment epithelial deposits. , 2007, Experimental eye research.
[25] B. Rosner,et al. Peripheral retinal drusen and reticular pigment: association with CFHY402H and CFHrs1410996 genotypes in family and twin studies. , 2009, Investigative ophthalmology & visual science.
[26] A Ralph Henderson,et al. The bootstrap: a technique for data-driven statistics. Using computer-intensive analyses to explore experimental data. , 2005, Clinica chimica acta; international journal of clinical chemistry.
[27] T. Peto,et al. A Population-Based Ultra-Widefield Digital Image Grading Study for Age-Related Macular Degeneration-Like Lesions at the Peripheral Retina. , 2015, Ophthalmology.
[28] B Efron,et al. Statistical Data Analysis in the Computer Age , 1991, Science.
[29] E. Agrón,et al. Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. , 2013, Ophthalmology.
[30] J. Ott,et al. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. , 2008, Ophthalmology.
[31] Matthew D. Davis,et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. , 2005, Archives of ophthalmology.
[32] Jennifer I. Lim,et al. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.
[33] Martin Krzywinski,et al. Sampling distributions and the bootstrap. , 2015, Nature methods.
[34] Elizabeth Rodriguez,et al. A Revised Mechanism for the Activation of Complement C3 to C3b , 2014, The Journal of Biological Chemistry.
[35] S. Perkins,et al. Uncontrolled zinc- and copper-induced oligomerisation of the human complement regulator factor H and its possible implications for function and disease. , 2008, Journal of molecular biology.
[36] E. Chew,et al. Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group. , 2017, Ophthalmology.
[37] G. Abecasis,et al. Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test? , 2015, Ophthalmology.
[38] G. Rocco,et al. Internal validation of risk models in lung resection surgery: bootstrap versus training-and-test sampling. , 2006, The Journal of thoracic and cardiovascular surgery.